17β-estradiol-dependent activation of signal transducer and activator of transcription-1 in human fetal osteoblasts is dependent on Src kinase activity

Endocrinology

Volumn 146, Issue 1, 2005, Pages 201-207

  Kennedy, Angela M ^a   Shogren, Kristen L ^a   Zhang, Minzhi ^a   Turner, Russell T ^a,b   Spelsberg, Thomas C ^b   Maran, Avudaiappan ^a,c  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; DNA; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; MUTANT PROTEIN; PROTEIN KINASE; SEX HORMONE; STAT1 PROTEIN; STEROID RECEPTOR COACTIVATOR KINASE; TYROSINE; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; PROTEIN TYROSINE KINASE; STAT1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; BINDING AFFINITY; BONE CELL; BREAST CANCER; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; DNA DETERMINATION; DNA SEQUENCE; DNA TRANSCRIPTION; DNA TRANSFECTION; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FETUS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TARGET CELL; CELL LINE; CYTOLOGY; DRUG EFFECT; ELECTROPHORESIS; ENZYMOLOGY; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

CELL LINE; DNA; DNA-BINDING PROTEINS; ELECTROPHORESIS; ESTRADIOL; FETUS; HUMANS; IMMUNOPRECIPITATION; OSTEOBLASTS; PHOSPHORYLATION; RECEPTORS, ESTROGEN; SRC-FAMILY KINASES; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 11144247247     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0486     Document Type: Article

References (40)

1. Griffin C, Flouriot G, Sonntag-Buck V, Nestor P, Gannon F 1998 Identification of novel chicken estrogen receptor-α messenger ribonucleic acid isoforms generated by alternative splicing and promoter usage. Endocrinology 139:4614-4625
2. Auchus RJ, Faqua SAWW 1994 Hormones-nuclear receptor in health disease. The oestrogen receptor. Baillieres Clin Endocrinol Metab 8:433-449
3. Sarrel PM, Lufkin EG, Oursler MJ, Keefe D 1994 Estrogen actions in arteries, bone and brain. Sci Am Sci Med 1:44-53
4. Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocr Rev 15:275-300
5. Kuiper GG, Gustafsson JA 1997 The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 410:87-90
6. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
7. Koike S, Sakai M, Muramatsu M 1987 Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res 15:2499-2513
8. Bonnelye E, Merdad L, Kung V, Aubin JE 2001 The orphan nuclear estrogen receptor-related receptor α (ERRα) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 153:971-984
9. Bonnelye E, Vanacker JM, Dittmar T, Begue A, Desbiens X, Denhardt DT, Aubin JE, Laudet V, Fournier B 1997 The ERR-1 orphan receptor is a transcriptional activator expressed during bone development. Mol Endocrinol 11:905-916
10. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
11. Yang NN, Venugopalan M, Hardikar S, Glasebrook A 1996 Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. [Erratum (1997) 275:1249]. Science 273:1222-1225
12. El-Tanani MK, Green CD 1997 Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol Endocrinol 11:928-937
13. Monroe DG, Spelsberg TC 2003 A case for estrogen receptors on cell membranes and nongenomic actions of estrogen. Calcif Tissue Int 72:183-184
14. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
15. Darnell Jr JE, Kerr IM, Stark GR 1994 Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421
16. Leaman DW, Leung S, Li X, Stark GR 1996 Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 10:1578-1588
17. Kaplan MH, Schindler U, Smiley ST, Grusby MJ 1996 Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313-319
18. Ihle JN, Kerr IM 1995 Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 11:69-74
19. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD 1998 How cells respond to interferons. Annu Rev Biochem 67:227-264
20. Bromberg J, Darnell Jr JE 2000 The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473
21. Bellido T, Borba VZ, Roberson P, Manolagas SC 1997 Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transauction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 138:3666-3676
22. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C 1999 FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13:1361-1366
23. Nishiyama T, Hatano H, Kurosaka M, Bolander ME, Sarkar G 2003 Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene. J Bone Miner Res 18:1716-1722
24. Harris SA, Enger RJ, Riggs BL, Speisberg TC 1995 Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178-186
25. Maran A, Zhang M, Spelsberg TC, Turner RT 2001 The dose-response effects of ethanol on the human fetal osteoblastic cell line. J Bone Miner Res 16:270-276
26. Reinholz GG, Getz B, Sanders ES, Karpeisky MY, Padyukova NSh, Mikhailov SN, Ingle JN, Spelsberg TC 2002 Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue. Breast Cancer Res Treat 71:257-268
27. Maran A, Maitra RK, Kumar A, Dong B, Xiao W, Li G, Williams BR, Torrence PF, Silverman RH 1994 Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265:789-792
28. Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BR, Stark GR 2000 Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways. EMBO J 19:263-272
29. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER 2002 Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277:50768-50775
30. Wong C, McNally CEN, Komm BS, Cheskis BJ 2002 Estrogen receptor-interacting protein that modulates its nongenomic activity-cross-talk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99:14783-14788
31. Bjornstrom L, Sjoberg M 2002 Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 16:2202-2214
32. Decker T, Lew DJ, Mirkovitch J, Darnell Jr JE 1991 Cytoplasmic activation of GAF, an IFN-γ-regulated DNA-binding factor. EMBO J 10:927-932
33. Decker T, Kovarik P, Meinke A 1997 GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 17:121-134
34. Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, Darnell Jr JE 1994 Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76:821-828
35. Sehgal PB 2000 STAT-signalling through the cytoplasmic compartment: consideration of a new paradigm. Cell Signal 12:525-535
36. Singh M, Setalo Jr G, Guan X, Warren M, Toran-Allerand CD 1999 Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19:1179-1188
37. Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE, Kamens J, Grandis JR 2003 Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem 278:31574-31583
38. Cao X, Tay A, Guy GR, Tan YH 1996 Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595-1603
39. Chaturvedi P, Reddy MV, Reddy EP 1998 Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation. Oncogene 16:1749-1758
40. Reddy EP, Korapati A, Chaturvedi P, Rane S 2000 IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 19:2532-2547